Skip to main content
Article
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
Journal for ImmunoTherapy of Cancer (2018)
  • Ryan J. Sullivan, Harvard University
  • Michael B. Atkins, Georgetown University
  • John M. Kirkwood, University of Pittsburgh
  • Sanjiv S. Agarwala, Temple University
  • Joseph I. Clark, Loyola University Medical Center
  • Marc S. Ernstoff, Roswell Park Cancer Institute
  • Leslie Fecher, University of Michigan
  • Thomas F. Gajewski, University of Chicago
  • Brian Gastman, Cleveland Clinic
  • David H. Lawson, Cancer Institute
  • Jose Lutzky, Mount Sinai Hospital
  • David F. McDermott, Beth Israel Deaconess Medical Center
  • Kim A. Margolin, City of Hope National Medical Center
  • Janice M. Mehnert, Cancer Institute
  • Anna C. Pavlick, New York University
  • Jon M. Richards, University of Pennsylvania
  • Krista M. Rubin, Harvard University
  • William Sharfman, Johns Hopkins University
  • Steven Silverstein
  • Craig L. Slingluff, University of Virginia
  • Vernon K. Sondak, University of South Florida
  • Ahmad A. Tarhini, Cleveland Clinic
  • John A. Thompson, Seattle Cancer Care Alliance
  • Walter J. Urba
  • Richard L. White, Carolinas Medical Center
  • Eric D. Whitman, Washington University in St. Louis
  • F. Stephen Hodi, Harvard University
  • Howard L. Kaufman, Harvard University
Publication Date
December 1, 2018
DOI
10.1186/s40425-018-0362-6
Citation Information
Ryan J. Sullivan, Michael B. Atkins, John M. Kirkwood, Sanjiv S. Agarwala, et al.. "An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0" Journal for ImmunoTherapy of Cancer Vol. 6 Iss. 1 (2018) p. 44
Available at: http://works.bepress.com/walter-urba/16/